Phase 1 data for DMX-1001 (noribogaine) support advancement into Phase 2 clinical trial in AUD AUD affects more than 29 million Americans and is a leading cause of preventable death; about 60 percent ...
The MarketWatch News Department was not involved in the creation of this content. -- Phase 1 data for DMX-1001 (noribogaine) support advancement into Phase 2 clinical trial in AUD -- AUD affects more ...
DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced positive results from its Phase 1 multiple ascending dose (MAD) study of ...
Lindsey Ellefson is Lifehacker’s Features Editor. She currently covers study and productivity hacks, as well as household and digital decluttering, and oversees the freelancers on the sex and ...
Machine learning is the ability of a machine to improve its performance based on previous results. Machine learning methods enable computers to learn without being explicitly programmed and have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback